IBS also see BOWEL DISORDERS

 

MARIJUANA AND IRRITABLE BOWEL SYNDROME (IBS)

(anecdotal- undated)                          http://www.rxmarihuana.com/christine.htm

 

Endometriosis by Kim                      (anecdotal – undated)

 

 

 

 

 

 

 

 

http://rxmarijuana.com/shared_comments/Endometriosis.htm

 

Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation.            (full – 2004)                              http://ajpgi.physiology.org/cgi/content/full/287/1/G7

 

Fibromyalgia, IBS, and the Endocannabinoid-CB-Receptor (ECBR) system (abst – 2004)                                      http://www.prohealth.com//library/showArticle.cfm?libid=10562

 

Cannabis-based drugs could offer new hope for inflammatory bowel disease patients (news – 2005)                                       http://www.medicalnewstoday.com/articles/28584.php

 

Potential new target for cannabis-derived drugs as a treatment of inflammatory bowel disease     (news – 2005)                           http://www.news-medical.net/news/2005/08/02/12175.aspx

 

Inflammatory Bowel Disease May Respond To Cannabis-Derived Drugs             (news – 2005)

http://www.medpagetoday.com/Gastroenterology/InflammatoryBowelDisease/1548

 

The role of the endocannabinoid system in the pathophysiology and treatment of irritable bowel syndrome.                                         (abst – 2008)      http://www.ncbi.nlm.nih.gov/pubmed/18710476

 

The role of fatty acid hydrolase gene variants in inflammatory bowel disease. (full – 2009)                                   http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2036.2008.03910.x/pdf

 

Cannabis Hope for Inflammatory Bowel Disease               (news – 2009)

http://www.sciencedaily.com/releases/2009/12/091220175502.htm

 

Cannabidiol reduces intestinal inflammation through the control of neuroimmune axis. (full – 2011)                                      http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3232190/?tool=pubmed

 

Is lipid signaling through cannabinoid 2 receptors part of a protective system? (full – 2011)                                  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3062638/

 

Pharmacogenetic Trial of a Cannabinoid Agonist Shows Reduced Fasting Colonic Motility in Patients with Non-Constipated Irritable Bowel Syndrome.                                                             (abst – 2011)  http://www.ncbi.nlm.nih.gov/pubmed/21803011

 

Cannabis use amongst patients with inflammatory bowel disease.              (abst – 2011)

http://www.ncbi.nlm.nih.gov/pubmed/21795981

 

Role of cannabinoid receptors and RAGE in inflammatory bowel disease.           (abst – 2011)

http://www.unboundmedicine.com/medline/ebm/record/21472688/abstract/Role_of_cannabinoid_receptors

_and_RAGE_in_inflammatory_bowel_disease_

 

The endogenous cannabinoid system in the gut of patients with inflammatory bowel disease.       (abst – 2011)  http://www.unboundmedicine.com/medline/ebm/record/21471961/abstract/The_endogenous_cannabinoid_  system_in_the_gut_of_patients_with_inflammatory_bowel_disease_

 

Irritable bowel syndrome: a dysfunction of the endocannabinoid system?             (full – 2012)

 

 

 

 

 

 

 

 

http://www.gastrojournal.org/article/S0016-5085%2811%2901710-0/fulltext

 

The Gastrointestinal Pharmacology of Cannabinoids: Focus on Motility.                     (full – 2012)

http://content.karger.com/produktedb/produkte.asp?DOI=000339072&typ=pdf

 

The endocannabinoid system in inflammatory bowel diseases: from pathophysiology to therapeutic opportunity.                                                           (abst – 2012)  http://www.ncbi.nlm.nih.gov/pubmed/22917662?dopt=Abstract

 

Randomized pharmacodynamic and pharmacogenetic trial of dronabinol effects on colon transit in irritable bowel syndrome-diarrhea.                                                               (abst – 2012)  http://www.ncbi.nlm.nih.gov/pubmed/22288893

 

Genetic Epidemiology and Pharmacogenetics in Irritable Bowel Syndrome. (abst – 2012)                                           http://www.ncbi.nlm.nih.gov/pubmed/22403795

 

Irritable Bowel Syndrome: Methods, Mechanisms, and Pathophysiology. Genetic epidemiology and pharmacogenetics in irritable bowel syndrome                                                      (abst – 2012)  http://ajpgi.physiology.org/content/302/10/G1075.abstract?maxtoshow=&hits=25&RESULTFORMAT=&f  ulltext=cannabinoid&searchid=1&FIRSTINDEX=105&sortspec=date&resourcetype=HWCIT

 

Cannabidiol in Inflammatory Bowel Diseases: A Brief Overview.                     (abst – 2012)

http://www.ncbi.nlm.nih.gov/pubmed/22815234

 

The endocannabinoid system in inflammatory bowel diseases: from pathophysiology to therapeutic opportunity.                                                           (abst – 2012)       http://www.ncbi.nlm.nih.gov/pubmed/22917662

 

Cannabinoid Receptor 1 Gene and Irritable Bowel Syndrome: Phenotype and Quantitative Traits.           (abst – 2013)                                            http://www.ncbi.nlm.nih.gov/pubmed/23306084

Share a link for